Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing ...

The antidepressant drugs market is set to experience significant growth in the coming years, driven by a rise in awareness of ...

The study is led by the university’s psychiatry, psychology, and clinical and translational science associate professor Dr ...

233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.

An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...

This paper reviews recent findings on the pharmacogenetics of antidepressant drugs and future clinical applications. Ultimately, these studies should lead to the use of genetic testing to guide ...

Results identify intestinal epithelial 5-HT as a new and potentially safer therapeutic target for mood regulation.

More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the ...

The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain ...

Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic ...

Apimostinel is an antidepressant drug that improves synaptic plasticity. Credit: Pormezz / Shutterstock. Gate Neurosciences and the University of Pittsburgh (Pitt) have commenced a Phase II clinical ...